Dr. Mayr is the CEO of Vector BioPharma. Prior to Vector BioPharma, Dr. Mayr has been the Chief Technology Officer for GE Healthcare Life Sciences and was responsible for all R&D investments, research programmes, business growth strategy, technology innovation, and R&D talent development across all business areas (BioProcess, Imaging Diagnostics/Contrast Media, Research Tools and Applied Markets, Cell & Gene Therapy, New Opportunities). Previously, he has been working as Vice President & Global Head, Reagents & Assay Development with responsibility for generation of all biological reagents and assay development activities across all therapeutic research areas at AstraZeneca.